Clinical trials
Recruiting Observational trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
153 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 6 |
| 2019 | 4 |
| 2020 | 8 |
| 2021 | 8 |
| 2022 | 7 |
| 2023 | 18 |
| 2024 | 20 |
| 2025 | 34 |
| 2026 | 29 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 153 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 13 |
| Hospital Israelita Albert Einstein | 10 |
| University of Sao Paulo General Hospital | 8 |
| University of Sao Paulo | 7 |
| Genzyme, a Sanofi Company | 4 |
| Hospital de Clinicas de Porto Alegre | 3 |
| Silimed Industria de Implantes Ltda | 3 |
| AO Foundation, AO Spine | 2 |
| AO Innovation Translation Center | 2 |
| Braile Biomedica Ind. Com. e Repr. Ltda. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiovascular Diseases | 5 |
| Coronary Artery Disease | 4 |
| Critical Illness | 4 |
| Neoplasms | 4 |
| Postoperative Complications | 4 |
| Pulmonary Disease, Chronic Obstructive | 4 |
| Acute Kidney Injury | 3 |
| Hypertension | 3 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Alzheimer Disease | 2 |
Trials
Showing 1 to 25 of 153. Each trial links to its page on Pharma Observatory.
53 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.